We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Pressure Management Guidelines to Be Loosened

By HospiMedica International staff writers
Posted on 31 Dec 2013
The update to the guidelines for the management of hypertension raises the blood pressure threshold that determines the need for drug therapy in many patients.

The recommendations by the expert panel appointed to the Eighth Joint National Committee (JNC 8) suggest that for most hypertensive individuals 60 years of age or older, pharmacologic treatment should be started when the systolic pressure is 150 mm Hg or higher or diastolic pressure is 90 mm Hg or higher, with the goal of achieving readings below those cutoffs. More...
For younger hypertensive patients and for those with chronic kidney disease or diabetes (regardless of age) treatment should be initiated when the systolic pressure is 140 or higher or the diastolic pressure is 90 or higher.

To develop the recommendations, the panelists reviewed evidence from randomized, controlled trials only, unlike JNC 7, which included multiple types of studies. The guideline was focused on three specific questions; the blood pressure thresholds used to initiate treatment, blood pressure goals, and appropriate drugs. For the initial choice of agent, the authors recommended that for nonblack individuals, including those with diabetes, ACE inhibitors, angiotensin receptor blockers (ARBs), calcium channel blockers, and thiazide-type diuretics could all be chosen for first-line treatment.

For black individuals, including those with diabetes, calcium channel blockers and thiazide-type diuretics are recommended as first-line therapy. For patients with chronic kidney disease, regardless of race or diabetes status, initial or add-on therapy should include an ACE inhibitor or an ARB to improve renal outcomes. To provide some guidance on how clinicians should combine and adjust doses of various drugs, the panelists included a treatment algorithm, while stressing the importance of clinical judgment. The guideline was published online on December 18, 2013, in the Journal of the American Medical Association (JAMA).

“Although this guideline provides evidence-based recommendations for the management of high blood pressure and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient,” stated panel co-chairs Paul James, MD, of the University of Iowa (Iowa City, USA) and Suzanne Oparil, MD, of the University of Alabama (Birmingham, USA), and colleagues.

The current guidance had a narrow focus and did not cover several subjects included in the JNC 7 recommendations, such as definitions of pre-hypertension and hypertension, measurement of blood pressure, patient evaluation, secondary hypertension, adherence to treatment regimens, resistant hypertension, and lifestyle interventions.

Related Links:

Eighth Joint National Committee



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Hybrid Arch Device
Neo EDE
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new Cora Torqueable Microcatheters expand our coronary portfolio supporting patients with coronary artery disease (photo courtesy of Reflow Medical)

Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions

Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.